Source: 4-TRADERS

PlasmaTech Biopharmaceuticals: Plasmatech Biopharmaceuticals : Abeona Therapeutics (Nasdaq: ABEO), formerly known as PlasmaTech Biopharmaceuticals, Inc. to Ring The Nasdaq Stock Market Closing Bell

(4-traders.com) (GlobeNewswire) - What: PlasmaTech Biopharmaceuticals announces name change to Abeona Therapeutics (Nasdaq:ABEO) to Reflect Broader Rare Disease Commitment and will visit the Nasdaq MarketSite in Times Square on Monday, June 22nd. Abeona Therapeutics is a biopharmaceutical company focused on developing and delivering gene therapy and...http://www.4-traders.com/PLASMATECH-BIOPHARMACEUTI-19344112/news/Plasmatech-Biopharmaceuticals--Abeona-Therapeutics-Nasdaq-ABEO-formerly-known-as-PlasmaTech-Bio-20571042/

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Tim Miller's photo - President & CEO of PlasmaTech Biopharmaceuticals

President & CEO

Tim Miller

CEO Approval Rating

70/100

Read more